Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

464 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-01

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to compare the efficacy of isolated coronary artery bypass grafting and coronary artery bypass grafting + mitral valve repair in moderate ischemic mitral regurgitation patients through a cohort and explore the potential risk factors of the clinical outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mitral Valve Repair Combined Coronary Artery Bypass Grafting(CABG) Verus CABG Alone on Functional Ischemic Mitral Regurgitation

NCT03525041

Coronary Artery Disease Mitral Valve Insufficiency

UNKNOWN NA

Surgical Treatment of Ischemic Mitral Regurgitation

NCT01368575

Mitral Valve Insufficiency

UNKNOWN PHASE4

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

NCT06917664

Coronary Artery Disease Ischemic Mitral Regurgitation Angiotensin Receptor/Neprilysin Inhibitor

RECRUITING PHASE4

Surgical Correction of Moderate Ischemic Mitral Regurgitation

NCT00394797

Moderate Ischemic Mitral Regurgitation

COMPLETED

Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation

NCT00806988

Mitral Valve Insufficiency Coronary Artery Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitral Valve Insufficiency Mitral Valve Annuloplasty Coronary Artery Bypass

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

coronary artery bypass grafting

mitral valve repair

Intervention Type PROCEDURE

coronary artery bypass grafting concomitant mitral valve repair

mitral valve repair

Intervention Type PROCEDURE

coronary artery bypass grafting concomitant mitral valve repair

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mitral valve repair

coronary artery bypass grafting concomitant mitral valve repair

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult coronary artery disease patients complicated with moderate ischemic mitral regurgitation.
2. undergoing coronary artery bypass grafting with or without mitral valve repair.

Exclusion Criteria

1. patients under the age of 18 years,
2. patients complicated with more than moderate ischemic mitral regurgitation or undergoing mitral valve replacement,
3. patients complicated with primary mitral valve disease other than ischemic mitral regurgitation, such as rheumatic mitral regurgitation or mitral valve leaflet prolapse,
4. patients undergoing concomitant aortic valve procedure.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No